A recent study using pan-cancer computer screening found that HOXB7 has value as a pan-cancer marker, and its expression in malignant tumors is also positively correlated with immune cell infiltration, immune regulatory genes, immune checkpoints, and TMB, which may be a potential immunotherapy indicator 54. Here, HOXB7 is linked to cancer.